in fact they do not have to wait too long it is not said that the market will become bull quickly and in the meantime other companies could pass them on...
the only hope is that competitors have the same problems getting funded. As long as no big pharmaceutical company invests in a competitor I think EHF still has a fighting chance.
Right now it comes down to how good their promoters are in catching rich private investors since community is not willing to put big bucks until the economy rises again.
If ehealth is not willing to care about the community, the community wont spent a penny for sure.
I do not even know if they have already given up.
